A simple yet multifaceted 90 years old, evergreen enzyme: Carbonic anhydrase, its inhibition and activation

CT Supuran - Bioorganic & Medicinal Chemistry Letters, 2023‏ - Elsevier
Advances in the carbonic anhydrase (CA, EC 4.2. 1.1) research over the last three decades
are presented, with an emphasis on the deciphering of the activation mechanism, the …

Emerging role of carbonic anhydrase inhibitors

CT Supuran - Clinical Science, 2021‏ - portlandpress.com
Inhibition of carbonic anhydrase (CA, EC 4.2. 1.1) was clinically exploited for decades, as
most modern diuretics were obtained considering as lead molecule acetazolamide, the …

Carbonic anhydrase and bacterial metabolism: a chance for antibacterial drug discovery

C Capasso, CT Supuran - Expert Opinion on Therapeutic Patents, 2024‏ - Taylor & Francis
ABSTRACT Introduction Carbonic anhydrases (CAs, EC 4.2. 1.1) play a pivotal role in the
regulation of carbon dioxide, bicarbonate, and hydrogen ions within bacterial cells, ensuring …

An overview of novel antimicrobial carbonic anhydrase inhibitors

CT Supuran - Expert Opinion on Therapeutic Targets, 2023‏ - Taylor & Francis
Introduction Four different genetic families of the enzyme carbonic anhydrase (CA, EC 4.2.
1.1) are present in bacteria, α-, β-, γ-and ι-CAs. They play relevant functions related to CO2 …

Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery

CT Supuran - Expert opinion on drug discovery, 2020‏ - Taylor & Francis
Introduction The spacious active site cavity of the metalloenzyme carbonic anhydrase (CA,
EC 4.2. 1.1) shows a great versatility for a variety of binding modes for modulators of activity …

Selected strategies to fight pathogenic bacteria

A Plotniece, A Sobolev, CT Supuran… - Journal of enzyme …, 2023‏ - Taylor & Francis
Natural products and analogues are a source of antibacterial drug discovery. Considering
drug resistance levels emerging for antibiotics, identification of bacterial metalloenzymes …

Antibacterial carbonic anhydrase inhibitors: an update on the recent literature

CT Supuran, C Capasso - Expert Opinion on Therapeutic Patents, 2020‏ - Taylor & Francis
Introduction The clinically licensed drugs used as antibiotics prevent the microbial growth
interfering with the biosynthesis of proteins, nucleic acids, microorganism wall biosynthesis …

Multi-and poly-pharmacology of carbonic anhydrase inhibitors

CT Supuran - Pharmacological reviews, 2024‏ - Elsevier
Eight genetically distinct families of the enzyme carbonic anhydrase (CA, EC 4.2. 1.1) were
described in organisms allover the phylogenetic tree. They catalyze the hydration of CO 2 to …

Bacterial ι-carbonic anhydrase: a new active class of carbonic anhydrase identified in the genome of the Gram-negative bacterium Burkholderia territorii

S Del Prete, A Nocentini, CT Supuran… - Journal of Enzyme …, 2020‏ - Taylor & Francis
The carbonic anhydrases (CAs, EC 4.2. 1.1) catalyse a simple but physiologically crucial
reversible reaction, the carbon dioxide hydration with the production of bicarbonate and …

Multiple Binding Modes of Inhibitors to Human Carbonic Anhydrases: An Update on the Design of Isoform-Specific Modulators of Activity

K D'Ambrosio, A Di Fiore, V Alterio, E Langella… - Chemical …, 2024‏ - ACS Publications
Human carbonic anhydrases (hCAs) are widespread zinc enzymes that catalyze the
hydration of CO2 to bicarbonate and a proton. Currently, 15 isoforms have been identified, of …